Post Reply
21-40 of 889
The &ldquo Sleep Well at Night&rdquo Portfolio: 4 SGX Stocks That Thrive in Market Chaos
Market volatility is unavoidable, but some businesses are built to handle uncertainty better than others. These four stocks stand out for their resilience, strong cash flow, and ability to stay steady when markets turn chaotic.
Share
Market sell-offs can be unnerving even for the most seasoned investors.
Here&rsquo s the hard part: the reasons for the sell-off differ every time &ndash think of the past five years, which included the pandemic, high inflation, recession fears, and geopolitical tensions &ndash there&rsquo s always a smart-sounding reason to sell.
You can fight back against this temptation by holding onto quality stocks that are structured to hold up better during turbulent times.
Then again, there is no amount of stocks you can own, even with a basket of these &ldquo Sleep Well at Night&rdquo stocks, that can eliminate portfolio volatility entirely.
Instead, what this cohort can do is give you peace of mind that after the storm, these businesses will emerge, hopefully stronger than before.
What Makes a &ldquo Sleep Well at Night&rdquo Stock
So, what qualities should a &ldquo Sleep Well&rdquo stock have?
In essence, we want the crè me de la crè me names that generate consistent, resilient cash flows regardless of market cycles.
Even better if these companies can maintain their dividend payouts during volatile periods.
Having a strong financial position with manageable debt levels can help buffer them against tough times.
Finally, the cherry on top would be for the companies to provide essential goods or services that will see steady demand even during downturns.
Remember, the key takeaway is that during periods of uncertainty, business resilience counts so much more.
Why Defensive Investing Still Matters in 2026
Investing conservatively is even more important during the uncertain times we&rsquo re living in.
With markets gyrating wildly with every headline coming out of the Middle East, combined with historically stretched valuations, we&rsquo ve seen some sharp movements both on the downside and upside so far this year.
In such an environment, you want to make sure you own resilient businesses that can help you stay invested while being reasonably assured of their survival moving forward.
DBS Group Holdings Limited (SGX: D05), or DBS &mdash The Defensive Dividend Anchor
The first name on the list is, in my opinion, the ultimate comfort stock.
Not only is DBS backed by Singapore&rsquo s Temasek Holdings, it has also been a consistent income provider with dependable dividends.
The local bank hasn&rsquo t missed an annual dividend since 2001.
Furthermore, DBS has been profitable for ten straight years, with net profits rising from S$4.4 billion in 2017 to S$11.3 billion in 2025.
This is the kind of resilience you want to see from a business.
Venture Corporation Limited (SGX: V03), or Venture Corp &mdash The Cash Flow Fortress
Venture Corp is another candidate for the &ldquo Sleep Well&rdquo cohort this business has generated positive free cash flow (FCF) for a decade, with annual FCF averaging around S$290 million.
This performance is noteworthy, given the challenging environments we have seen across the decade.
Although FCF has been volatile in the past few years, Venture Corp&rsquo s ability to post positive FCF consistently adds strong financial flexibility that helps cushion against downturns.
Furthermore, it boasts an enviable balance sheet with a strong net cash position exceeding S$1 billion.
The key takeaway is that being a consistent generator of cash flows strengthens a business&rsquo s resilience.
Singapore Exchange Limited (SGX: S68), or SGX &mdash The Essential Services Provider
Next, SGX is a business that thrives during market chaos.
The bourse operator earns fees from transactions conducted on its exchange.
During volatile markets, transaction volumes rises, and as a result, SGX usually does pretty well.
In fact, amid the Great Financial Crisis in 2008 and 2009, SGX&rsquo s annual dividend peaked at S$0.38 per share.
SGX&rsquo s top-line growth has been steady as well, increasing from around S$801 million in the fiscal year ended 30 June 2017 (FY2017) to nearly S$1.4 billion in FY2025.
Consistent demand for a business&rsquo s products and services is a powerful mitigant against market uncertainty.
CapitaLand Integrated Commercial Trust (SGX: C38U), or CICT &mdash The Long-Term Compounder
Finally, having a strong market position can allow a business to emerge stronger after a market crisis.
CICT, with its status as the largest REIT in Singapore, is a great example of such a business.
In recent times, the REIT has taken advantage of market downturns to beef up its portfolio, as seen in its expansion into Australia in 2021 and the acquisition of CapitaSky in 2022.
CICT is big enough that it&rsquo s actually growing while everyone else is focused on keeping the lights on.
How to Build a Portfolio That Helps You Sleep Better
On your end, to keep your portfolio steady, make sure you&rsquo re not putting all your money into one industry.
Also, avoid borrowing money for stocks and stay away from hyped-up names that don&rsquo t have the profits to back up their lofty stock prices.
Do focus on a business&rsquo s long-term fundamentals and do not be swayed by daily price action or market headlines.
The worst thing you can do is to sell a quality business that is under share price pressure due to general market conditions.
So, do your best to manage your emotions trust that you have done a decent job (following the above) in constructing a portfolio that should stand up well in the midst of market volatility.
Get Smart: The Best Portfolios Reduce Stress, Not Just Risk
In sum, investing does not mean you have to pay attention to each headline and price action daily.
Owning a well-diversified portfolio of wonderful businesses that have a proven capacity to generate consistent cash flows can help you better deal with periods of uncertainty.
Remember, staying invested in the market matters most.
Oil prices are rising. Markets are swinging. And headlines are getting louder by the day.
In times like this, many investors look for predictions. But in our experience, what matters more is having a framework.
In this upcoming webinar, Chin Hui Leong shares how we approach volatile markets through three layers: what to buy, when to deploy capital, and how to build conviction in the businesses we own.
Because uncertainty is not something to avoid. It is something to prepare for.
GOOD NIGHT. SWEET DREAMS...
Stop Watching the Tickers: 5 Stocks to &ldquo Buy and Forget&rdquo for a Decade
Constantly checking stock prices rarely builds wealth. The real gains often come from holding great businesses over time. These five stocks are the kind investors can consider owning for the next decade.
Building long-term wealth isn&rsquo t about watching stock tickers, chasing headlines, or reacting to every price movement daily.
Instead, it is about owning quality businesses that you can &ldquo buy and forget.&rdquo
What &ldquo Buy and Forget&rdquo Really Means
To be sure, taking this stance does not mean you should ignore your investments after you buy them.
It simply means selecting businesses that you can trust for the long run.
You hold them through market cycles and allow compounding to do its work instead of reacting to short-term noise.
Compounding is something that should be left to work for years and not weeks, let alone days.
What Makes a Stock Suitable for Long-Term Holding
Stocks with a strong economic moat that can protect their earnings are candidates for long-term investing.
Another plus point is when the company focuses on long-term value creation and not short-term gains.
Additionally, these high-quality picks will also have a history of consistent earnings growth.
DBS Group &mdash The Global Platform Leader
DBS Group (SGX: D05) became Southeast Asia&rsquo s largest bank in 1998.
Today, it has operations spanning 19 markets with a keen focus on Greater China, Southeast Asia and South Asia, a network that is hard to match.
For the full year of 2025 (FY2025), DBS achieved a record total income of S$22.9 billion.
The local bank didn&rsquo t lose any steam heading into the first quarter of 2026 (1Q2026) with total income reaching a new high of almost S$6 billion.
That&rsquo s despite net interest income (NII) slipping 5% YoY due to a lower net interest margin.
DBS is still no doubt the leader among our local banks.
Its current market cap of S$171 billion, as of 14 May 2026, is ahead of Oversea-Chinese Banking Corporation (SGX: O39), or OCBC, and United Overseas Banking (SGX: U11), or UOB, which reported market capitalisations of S$103 billion and S$62 billion respectively.
But wait, there&rsquo s more to consider.
DBS is not just the largest &mdash it has scored a return on equity (ROE) of 17% for 1Q2026 on an annualised basis, easily beating OCBC (13%) and UOB (11.5%).
ST Engineering &mdash The Dividend Growth Blue Chip
Global technology and defence powerhouse, ST Engineering (SGX: S63) or STE, is backed by government contracts and long-term aviation maintenance.
The company won S$18.7 billion worth of new contracts in 2025, and ended the year with a massive order book of S$33.2 billion.
The conglomerate has not slowed down in 2026, securing an additional S$4.8 billion in new contracts across its business segments in the first three months of the year.
Having a multi-year order book allows the company to &ldquo lock in&rdquo years of future work, providing highly visible and stable income for the next few years.
To improve total shareholder return, STE intends to distribute one-third of any YoY profit increase as incremental dividends.
The group has displayed continuous dividend increments over the years.
Total dividends for 2025 amounted to S$0.23 per share, a 35% increase over the 2024 dividend of S$0.17, and a 44% increase compared to the S$0.16 paid in 2023.
Notably, 2025&rsquo s dividend included a S$0.05 special dividend.
Venture Corp &mdash The Structural Growth Leader
Venture Corp (SGX: V01) serves as a strategic partner and manufacturer for global giants in key sectors such as life sciences and advanced networking.
With the worldwide push for better medical technology and rising complexity of semiconductor testing, Venture Corp is well-positioned to benefit from the increasing sector demand.
As of 31 March 2026 (the end of 1Q2026), the company has a net cash position of S$1 billion.
This substantial cash surplus has been sustained even after accounting for consistent dividend payouts and share buybacks, reflecting the company&rsquo s ability to grow.
Sheng Siong &mdash The Defensive Compounder
As a classic all-weather stock, Sheng Siong (SGX: OV8) remains resilient regardless of the economy as daily groceries and household essentials never go out of style.
In fact, when times get tough, consumers cut down on dining out and eat at home instead.
And where do they go to get cheaper groceries?
That&rsquo s right &mdash Sheng Siong.
The company&rsquo s performance backs this up.
In 2025, revenue rose by nearly 10% YoY to S$1.6 billion, while maintaining a gross profit margin of 31.3%.
The momentum continued into 1Q2026, with revenue jumping 12.4% YoY to S$452.8 million even as the gross profit margin slipped slightly to 31%.
Additionally, the supermarket chain holds over S$461.1 million in cash and cash equivalents with zero debt.
Combined with a consistent gross profit margin of approximately 30%, Sheng Siong is clearly capable of providing long-term investors with predictable cash flows and stable dividends.
Keppel DC REIT &mdash The Scalable Challenger
As of 31 December 2025, Keppel DC REIT (SGX: AJBU) has 25 data centres across Asia-Pacific and Europe valued at S$6.3 billion.
With a portfolio occupancy of 95.8% and a weighted average lease expiry (WALE) of 6.7 years as of the end of 1Q2026, tenants are locked in for the long haul.
Plus, a built-in rental escalation clause tied to inflation has been implemented to help offset any costs that may eat into unitholder returns.
With technology giants like Microsoft Corp (NASDAQ: MSFT) and Alphabet (NASDAQ: GOOGL) pouring billions into artificial intelligence (AI), global data centre capacity is expected to double by 2030.
Keppel DC REIT has intentionally focused on stabilised assets in supply-constrained markets, allowing its assets to benefit from the &ldquo supply squeeze.&rdquo
Established players like Keppel DC REIT can keep occupancy high and leasing conditions favourable.
Why Most Investors Struggle to &ldquo Hold for a Decade&rdquo
More often than not, when the stock prices fall, investors&rsquo loss aversion instinct kicks in and they end up panic selling.
Investors who get swayed will make impulsive decisions that negatively impact their long-term goals.
Usually those who fail to do their due diligence before investing find it hard to remain invested.
Without a solid understanding of the business, they lack the foundation necessary to justify holding their position when things get shaky.
The secret to long-term holding is very simple.
Just shift your focus from daily price changes to underlying business performance.
Stop monitoring your portfolio constantly &ndash you only need to review your holdings periodically, say every six months, to ensure your investment thesis remains intact.
Get Smart: Wealth Is Built in the Waiting
When you plant a seed, watching it closely every day wouldn&rsquo t make the plant grow faster.
The true source of wealth is not constant activity, but rather the product of owning high-quality businesses over extended periods.
The real challenge of investing only begins after you have identified the right stocks.
It lies in having the discipline to &ldquo let go&rdquo and allow their performance to deliver powerful results over time.
Philip Morris rises as IQOS regulatory clarity and smoke-free growth narrative stay in focus
Philip Morris International Inc. (PM) is up 3.0% today. Here is some analysis on what might have caused this price movement.
Analysis: The move likely reflects renewed investor focus on U.S. regulatory clarity for IQOS and PMI&rsquo s broader smoke-free growth story, following recent FDA actions and company updates. With IQOS and other smoke-free products positioned as key earnings drivers, any sign of reduced regulatory uncertainty can support a higher valuation multiple.
Details:
- The FDA renewed authorization for five IQOS products to be marketed with exposure modification claims, a development that supports continued U.S. marketing of IQOS-related reduced-exposure messaging for adult consumers.
- PMI announced the U.S. FDA reauthorization of IQOS as a Modified Risk Tobacco Product (MRTP), highlighting that the renewal allows it to continue communicating reduced-exposure information to U.S. adults 21+ who use traditional tobacco products.
- In its April 22, 2026 first-quarter update, PMI emphasized continued momentum in IQOS volumes and market share in key regions and maintained/updated its 2026 adjusted EPS forecast for currency only, reinforcing the durability of its smoke-free-led growth profile.
- This could also be helped by &ldquo defensive&rdquo rotation into consumer staples on a risk-off tape, which often benefits large dividend-paying tobacco names even without a single breaking headline.
Sources:
U.S. Food and Drug Administration, Philip Morris International, U.S. Securities and Exchange Commission
Smoky skies ahead...can' t see clearly :)
tongphlp ( Date: 08-May-2026 16:14) Posted:
|
short!
Alignment ( Date: 13-May-2026 19:59) Posted:
|
AEM will overtake this very soon and become the darling of SGX!
Alignment ( Date: 13-May-2026 19:59) Posted:
|
no wonder analysts are shouting for $21....
Alignment ( Date: 13-May-2026 19:59) Posted:
|
AI business already doing well. If life sciences also takes off then it will really be firing on all cylinders.
tongphlp ( Date: 12-May-2026 09:44) Posted:
|
Venture, SG1V12936232
Venture Corp Ltd shares traded at S$18.01 on May 11, 2026 on SGX after a 1.21% drop, while an analyst lifted the target price to S$21.80 from S$17.40.
Venture, SG1V12936232
Venture Corp Ltd (SGX: V03) saw its stock price decline 1.21% to S$18.01 on May 11, 2026 on the Singapore Exchange, according to stockinvest.us as of May 11, 2026. Separately, an analyst raised the target price to S$21.80 from S$17.40, signaling optimism amid the semiconductor cycle recovery, per moomoo as of recent update.
As of: 12.05.2026
By the editorial team &ndash specialized in equity coverage.
Official source
For first-hand information on Venture Corp Ltd, visit the company&rsquo s official website. Go to the official website
Venture Corp Ltd provides electronics manufacturing services (EMS) across multiple sectors including semiconductors, life sciences and consumer electronics. The company operates globally with facilities in Asia, North America and Europe, serving clients like Intel and ASE Technology, as noted in The Smart Investor coverage. This diversified model helps mitigate sector-specific risks.
Headquartered in Singapore and listed on the SGX Mainboard under ticker V03, Venture focuses on design, engineering and manufacturing solutions. Its balanced exposure positions it well in the semiconductor upcycle, relevant for US investors tracking global supply chains.
Key revenue comes from semiconductor testing equipment, medical devices and networking hardware. The semiconductor segment benefits from partnerships with major chipmakers, driving growth amid industry recovery. Life sciences contribute through precision manufacturing for healthcare tech.
Consumer electronics remain a steady driver, though cyclical. Recent price action shows resilience, with the stock at S$18.01 on May 11, 2026 on SGX per stockinvest.us as of May 11, 2026, offering exposure to Asia' s tech boom for US portfolios.
The semiconductor cycle is turning positive, boosting EMS providers like Venture Corp Ltd. Demand for advanced testing solutions rises with AI and 5G chip complexity. Venture' s partnerships with Intel enhance its competitive edge in this space.
In life sciences, growing medtech needs support margins. US investors note Venture' s role in global supply chains, with North American operations aiding exposure to US tech giants without direct Nasdaq listing.
Venture Corp Ltd offers US investors indirect play on Asia semiconductor growth via SGX listing. Its diversified revenue reduces volatility compared to pure chip plays. Analyst target hikes to S$21.80 reflect upside potential amid sector tailwinds.
Trading in SGD on SGX, shares are accessible via many US brokers, providing portfolio diversification into high-growth EMS.
Read more
Additional news and developments on the stock can be explored via the linked overview pages.
More news on this stockInvestor relations
Venture Corp Ltd combines EMS expertise across semiconductors and life sciences, with recent analyst upgrades and stable pricing amid cycle recovery. The SGX-listed stock provides US investors global tech exposure. Market dynamics will shape near-term performance.
Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.
Venture Corp Ltd stock (SG1V12936232): Analyst raises target to S$21.80
12.05.2026 - 08:37:40 | ad-hoc-news.deVenture Corp Ltd shares traded at S$18.01 on May 11, 2026 on SGX after a 1.21% drop, while an analyst lifted the target price to S$21.80 from S$17.40.
Venture Corp Ltd (SGX: V03) saw its stock price decline 1.21% to S$18.01 on May 11, 2026 on the Singapore Exchange, according to stockinvest.us as of May 11, 2026. Separately, an analyst raised the target price to S$21.80 from S$17.40, signaling optimism amid the semiconductor cycle recovery, per moomoo as of recent update.
As of: 12.05.2026
By the editorial team &ndash specialized in equity coverage.
At a glance
- Name: Venture Corporation Limited
- Sector/industry: Information Technology / Electronic Equipment
- Headquarters/country: Singapore
- Core markets: Semiconductors, life sciences, consumer electronics
- Home exchange/listing venue: SGX Mainboard (V03)
- Trading currency: SGD
Official source
For first-hand information on Venture Corp Ltd, visit the company&rsquo s official website. Go to the official website
Venture Corp Ltd: core business model
Venture Corp Ltd provides electronics manufacturing services (EMS) across multiple sectors including semiconductors, life sciences and consumer electronics. The company operates globally with facilities in Asia, North America and Europe, serving clients like Intel and ASE Technology, as noted in The Smart Investor coverage. This diversified model helps mitigate sector-specific risks.
Headquartered in Singapore and listed on the SGX Mainboard under ticker V03, Venture focuses on design, engineering and manufacturing solutions. Its balanced exposure positions it well in the semiconductor upcycle, relevant for US investors tracking global supply chains.
Main revenue and product drivers for Venture Corp Ltd
Key revenue comes from semiconductor testing equipment, medical devices and networking hardware. The semiconductor segment benefits from partnerships with major chipmakers, driving growth amid industry recovery. Life sciences contribute through precision manufacturing for healthcare tech.
Consumer electronics remain a steady driver, though cyclical. Recent price action shows resilience, with the stock at S$18.01 on May 11, 2026 on SGX per stockinvest.us as of May 11, 2026, offering exposure to Asia' s tech boom for US portfolios.
Industry trends and competitive position
The semiconductor cycle is turning positive, boosting EMS providers like Venture Corp Ltd. Demand for advanced testing solutions rises with AI and 5G chip complexity. Venture' s partnerships with Intel enhance its competitive edge in this space.
In life sciences, growing medtech needs support margins. US investors note Venture' s role in global supply chains, with North American operations aiding exposure to US tech giants without direct Nasdaq listing.
Why Venture Corp Ltd matters for US investors
Venture Corp Ltd offers US investors indirect play on Asia semiconductor growth via SGX listing. Its diversified revenue reduces volatility compared to pure chip plays. Analyst target hikes to S$21.80 reflect upside potential amid sector tailwinds.
Trading in SGD on SGX, shares are accessible via many US brokers, providing portfolio diversification into high-growth EMS.
Read more
Additional news and developments on the stock can be explored via the linked overview pages.
More news on this stockInvestor relations
Conclusion
Venture Corp Ltd combines EMS expertise across semiconductors and life sciences, with recent analyst upgrades and stable pricing amid cycle recovery. The SGX-listed stock provides US investors global tech exposure. Market dynamics will shape near-term performance.
Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.
shared by a forumer:
Venture hit 17 Again 👏
&zwnj https://youtu.be/jdXXaR_7DmU?si=904HfP_gDUInEXZ2...
&zwnj At its peak in 2018, Venture share price almost hit 🎯 30 dollars, at that time DBS share was also hit its peak around 31 dollars..
&zwnj Now, after it went XD, it propelled even higher and hit 17 again.. When OCBC hit 17 again last year, this song was featured and went on to hit 22 dollars, will Venture hit 22 dollars in the later part of the year? 🤔
&zwnj Vested. 🤭
Venture hit 17 Again 👏
&zwnj https://youtu.be/jdXXaR_7DmU?si=904HfP_gDUInEXZ2...
&zwnj At its peak in 2018, Venture share price almost hit 🎯 30 dollars, at that time DBS share was also hit its peak around 31 dollars..
&zwnj Now, after it went XD, it propelled even higher and hit 17 again.. When OCBC hit 17 again last year, this song was featured and went on to hit 22 dollars, will Venture hit 22 dollars in the later part of the year? 🤔
&zwnj Vested. 🤭
More revenue streams coming?
Venture partners with Cellanome to develop new cell imaging instrument
Venture is honored to have partnered with Cellanome to develop and manufacture its groundbreaking new instrument, which empowers humankind to capture the intricacies of cells and their interactions, with unprecedented scale, resolution, and context necessary to unravel biological complexity. Cellanome&rsquo s innovations lie in its combination of fluorescent, live-cell imaging, and single-cell studies with proprietary CellCage&trade technology. Together these capabilities support high-resolution, large-scale studies, from single cells to complex ensembles. With our proven track record in the Life Science domain, Venture brings differentiated capabilities in design and manufacturing, including our expertise in precision optics, motion control, thermal management, fluidics, and system controls. Our collaboration with Cellanome accelerated time-to-market and ensures scalable, high-quality design for manufacturability and commercialisation. The successful deployment of this product is a testament to the strong synergies between the Cellanome and Venture teams in bringing transformative innovation to market.
The &ldquo Semiconductor Cycle&rdquo : Is It Time to Buy AEM and Venture Corp Again?
Semiconductor stocks are highly cyclical &mdash as the cycle turns, investors are asking if AEM and Venture Corp are poised for a rebound.
Share
The semiconductor industry is notorious for its wild boom and bust cycles, with large fortunes made (or lost), depending on when you invested.
Intel&rsquo s (NASDAQ: INTC) recent earnings beat and optimistic chip demand forecast have helped put semiconductor stocks back in focus for investors.
In Singapore, AEM Holdings Limited (SGX: AWX) and Venture Corporation Limited (SGX: V03) are two primary stocks for semiconductor exposure.
Are these names still a buy here?
Understanding the Semiconductor Cycle
First, let&rsquo s shed some light on why the semiconductor industry is highly cyclical.
Demand for chips usually grows when there is economic growth (more demand for electronics) or technology advancements (think AI/cloud).
To meet this increase in demand, semiconductor companies generally increase the supply of chips. Traditionally, this leads to inventory build-up and overcapacity of chips.
When a slowdown in demand hits, chip inventories outweigh demand, leading to a decrease in the pricing of chips. Companies will then reduce chip production capacity while their inventories of chips get drawn down.
Finally, the whole cycle repeats itself when we see an economic recovery or a change in technology.
The key takeaway is that timing in the semiconductor industry matters, but predicting exact turning points is difficult.
Where Are We in the Cycle Today?
There have been some encouraging signs seen in the semiconductor industry: other than strong demand for AI-related chips, analog chips (chips that interact with the physical world and which tend to serve automotive and industrial use cases) are seeing signs of stabilisation.
Strong earnings and optimistic outlooks from leaders such as Intel and Texas Instruments (NASDAQ: TXN) confirm that chip demand remains high.
However, the conflict in the Middle East is creating supply chain risks and economic uncertainty that could weigh on the sector.
With possible higher inflation and softer purchasing power among consumers, the possible slowdown in demand for consumer electronics could also hurt chipmakers.
Company Overview: AEM vs Venture Corp
Of the two companies, AEM presents a purer play on the semiconductor industry. It provides testing solutions for semiconductors and electronics.
AEM has partnerships inked with leading global chipmakers, including Intel and ASE Technology Holding Co Ltd (TPE: 3711).
Historically, AEM&rsquo s business has been rather volatile given its single-customer concentration risk with Intel. But this has improved slightly in more recent years as AEM has expanded its customer base.
AEM&rsquo s stock price has been on an absolute tear, last trading at S$7.58, nearing the upper-end of its wide 52-week range (S$1.19 &ndash S$8.36). Its results for 2025 partly explain this strong rally.
Although topline growth was tepid at 5%, the true story is seen in AEM&rsquo s bottom-line expansion: Net profit surged a staggering 47.8% to S$17.1 million, as the company ramps up manufacturing for its second AI/HPC (high-performance computing) customer. Operating margin also improved to 5.3%, from 2024&rsquo s 3.7%. Meanwhile, AEM&rsquo s return on equity (ROE) of 3.4% for 2025 is a marginal improvement from 2024&rsquo s 2.4%.
Crucially, operating cash flow (OCF) swung positive to S$133.6 million, with a healthy S$112.1 million in free cash flow (FCF), up from a negative figure in 2024. AEM used the increase in FCF to pay down a majority of its debt, leaving the balance sheet in a solid net cash position of S$61.0 million.
On the other hand, Venture Corp offers a more balanced exposure to semiconductors. It offers electronics manufacturing services to a wide variety of industries, including semiconductors, life sciences, and consumer electronics.
With a more diversified customer base across industries, Venture Corp has generated consistently positive earnings and cash flows through market cycles.
Venture Corp&rsquo s shares are currently trading at S$17.96 each, near the top of the annual range of S$10.92 &ndash S$18.75.
In its latest set of results, which were for 2025, Venture Corp saw its revenue soften by 7.4% to S$2.5 billion, with net profit also declining by the same percentage to S$227 million. These numbers were the result of weakness in the company&rsquo s consumer technology segment. However, a bright spot is that operating margin inched up to 9.6% from 9.4% in 2024.
ROE did step down moderately to 8.0% from 2024&rsquo s 8.5%. However, the company still managed to generate positive free cash flow of S$226.3 million. Venture Corp&rsquo s balance sheet remains robust, with an excellent net cash position of S$1.3 billion.
The Bull Case: Why It Might Be Time to Buy
The rebound in demand for analog chips, alongside strong AI demand, has painted a constructive demand picture for semiconductors.
Both AEM and Venture Corp might see stronger earnings growth because of the supportive demand backdrop for semiconductors.
The Bear Case: Why Investors Should Be Cautious
However, investors should still consider the possible bear case facing semiconductors, where recovery in certain sub-segments (consumer electronics) may remain weak or take longer than expected to come to fruition.
AEM&rsquo s heavy reliance on a few key customers also presents a significant concentration risk.
Valuation: Are These Stocks Cheap Enough?
AEM looks expensive, with a forward price to earnings (P/E) ratio of 55.2x, nearly triple its five-year average of 19.5x, suggesting lofty growth expectations in the eyes of investors.
Meanwhile, Venture Corp trades at a forward P/E ratio of 21.5x, against its five-year average of 15.3x, possibly showing a turnaround priced in by investors.
Get Smart: Aggressive Growth or Defensive Value?
For investors comfortable with a more volatile name, albeit one with stronger prospects, AEM may be the better fit.
For investors who prize greater stability and dividends, consider having Venture Corp as your semiconductor exposure.
In sum, to invest in semiconductors, you have to be mindful of which part of the cycle we&rsquo re currently in.
Both AEM and Venture Corp offer exposure to the semiconductor sector, with the former being a more aggressive option and the latter a more conservative pick.
At the end of the day, the right fit for your portfolio depends on your risk profile and time horizon.
When the market corrects, most people see a crisis. We see an opportunity to apply a system.
While others are paralysed by mixed signals from the energy sector and tech stocks, we&rsquo re sticking to a practical framework that filters the noise.
A market dip can either hurt your returns&hellip or accelerate them.
The difference comes down to one thing: how you deploy your cash.
Disclosure: Wilson.H does not own shares in any of the companies mentioned.